Our medical team uses AOD-9604 as part of comprehensive body composition programs that combine peptide therapy with nutritional guidance, lifestyle optimization, and complementary treatments when appropriate
Concurrent medications should be carefully reviewed, as many drugs can affect memory independently of Zepbound
In the context of MASLD/MASH, analogous rebound phenomena would be expected: regression of achieved steatosis resolution and potential re-emergence of inflammatory activity and fibrogenic stimuli upon drug withdrawal
Its easier than you think
Neuroscientist Gregg Stanwood, Ph.D., said in a May 24 segment on TODAY that there's a growing sense that semaglutide "appears to blunt the effects of dopamine in the brain," aka the feel-good chemical, which reduces cravings because patients don't get the same high from these activities that they did previously
Novo Nordisk is the ONLY entity holding a patent for Semaglutide